Analysts Shared Their Read on 2 Stocks: MAG Silver Corp. (MAG), Anthera Pharmaceuticals, Inc. (ANTH)

The opening price for MAG Silver Corp. (NYSE:MAG) was $11.54 and the volume amounted to 0.31 million shares which compares with the average volume of 285.76 million shares. The company stock experienced a 3.27% move to arrive at $12.

MAG Silver Corp. (MAG) Analyst Opinion

MAG Silver Corp. has a consensus outperform rating from 9 Wall Street analysts, and the number of shares currently sold short amount to at least 2.68% of shares outstanding. The stock sank -6.4% last month and is up 8.79 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover MAG having a buy-equivalent rating. Analysts have placed a $18.35 price target on MAG Silver Corp., suggesting a 52.92% gain from recent close. It’s currently trading about -28.49% below its 52-week high.

MAG Silver Corp. (NYSE:MAG) Intraday View

This stock (MAG) is ahead of its 52-week low with 26.32%. Its last month’s stock price volatility remained 3.17% which for the week stands at 2.84%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.1% and stays -3.19% away from its 50 days moving average. Over the last five days, shares have managed 6.86% gains and now is down -7.27% since hitting its 200-day moving average of $12.59. MAG Silver Corp. (MAG) has made its way to a 12-month decline of -10.91%.

Turning to Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), its shares were trading at $1.65 a retreat of $-0.06, on the trading floor. The stock, after opening at $1.7, touched a high of $1.74 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.6. Anthera Pharmaceuticals, Inc. has 0 buy ratings, 3 holds and 0 sells even after the stock tumbled -93.97% from its high of $3.27 to a $19.68 million market value through last close.

Anthera Pharmaceuticals, Inc. (ANTH) Consensus Price Target

The company’s consensus rating on Reuter’s scale slipped from 2.75 to 2.6 during a month. Analysts set a 12-month price target of $6.75 a share. The target implies a 309.09% spike from where the shares are currently trading. Also, the current price highlights a discount of 142.42% to analysts’ high consensus price target.

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Intraday Trading

The counter witnessed a trading volume of 0.42 million shares versus an average volume of 379.89 million shares during last trading session. Its last month’s stock price volatility remained 16.2% which for the week approaches 8.63%. The lowest price the stock reached in the last trading day was $1.62 and compares with the $0.3 52-week low. The stock recovered 37.5% since its low point and has performed -68.23% year-to-date.

Previous articleAnalyzing Stocks On Analyst Opinion: Planet Payment, Inc. (PLPM), Denbury Resources Inc. (DNR)
Next articleAnalysts Are Gushing Over Lannett Company, Inc. (LCI), Streamline Health Solutions, Inc. (STRM)